GW Pharmaceuticals And Greenwich Biosciences Announce FDA Acceptance Of sNDA Filing With Priority Review For EPIDIOLEX In Treatment Of Seizures Associated With Tuberous Sclerosis Complex
Benzinga Newsdesk